Genpharmasec has published its audited consolidated and standalone financial results for the quarter and year.

For the full year, consolidated total income from operations was 143.09 Cr, achieving a net profit after tax of 0.56 Cr, with basic EPS at 0.01. For the final quarter alone, consolidated income reached 56.44 Cr and net profit after tax was 1.35 Cr.

Standalone results for the year showed total income from operations at 156.22 Cr and a net profit of 0.81 Cr.

These results offer shareholders a comprehensive overview of the company's annual and quarterly financial performance.